首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Addiction

缩写:ADDICTION

ISSN:0965-2140

e-ISSN:1360-0443

IF/分区:5.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引6213
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Tobias B Atkin,Frances R Levin,John Mariani et al. Tobias B Atkin et al.
Background: Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a pr...
Mark Pawson,Mike Vuolo,Brian C Kelly Mark Pawson
Aims: Within a context of considerable cannabis market expansion and product diversification, cannabis consumers must manage their use across a range of potencies and modes of consumption. This study aimed to provide deep...
Jennifer McNeely,Geetha A Subramaniam,Rebecca Stone et al. Jennifer McNeely et al.
Background and aims: Individuals who engage in illicit or nonmedical opioid use may have elevated risk of health and social consequences, including progression to opioid use disorder (OUD). Preventive interventions to red...
Samuel Mann,Daniel Siconolfi,Anthony Rodriguez et al. Samuel Mann et al.
Background and aims: Alcohol-Free and Low-Alcohol Beverages (AFLABs) have grown in popularity, yet predictors and longitudinal outcomes of their use remain unclear. We aimed to measure the association between AFLAB consum...
Amy Bagshaw,Suleyman Shah,India Olchefske et al. Amy Bagshaw et al.
Background and aims: Despite the well-documented benefits of opioid substitution treatment (OST) in treating opioid dependence (OD), many people diagnosed with OD desire to live a drug-free life. The transition to abstine...
Mia Miller,Nicola Man,Nicholas Taylor et al. Mia Miller et al.
Background and aims: A minimum unit price (MUP) of AUD$1.30 per standard drink was implemented in 2018 in the Northern Territory (NT), Australia, to reduce the availability of cheap alcohol. Despite evidence of its effica...
Emmert Roberts,Elizabeth Sanderson,Thomas Santo Jr et al. Emmert Roberts et al.
Background and aims: Naltrexone is a pharmacotherapeutic option for relapse prevention in opioid use disorder (OUD); however, studies highlight low rates of initiation and high rates of discontinuation as limiting its eff...
Megan S Schuler,Rebecca Weir,Colleen M McCullough et al. Megan S Schuler et al.
Background and aims: Individuals with opioid use disorder (OUD) frequently present with co-occurring mental health conditions such as depression and posttraumatic stress disorder (PTSD), along with other mental health sub...
Salma Mahmoodianfard,Spencer Shahen,Javad Heshmati et al. Salma Mahmoodianfard et al.
Background and aims: Oral nicotine pouches (NPs) are a new class of non-combustible nicotine products that have gained rapid popularity. Despite rising sales and marketing, evidence of their prevalence and risk perception...